Renmin Hospital of Wuhan University, Cancer Center, Wuhan 430071, PR China.
Renmin Hospital of Wuhan University, Cancer Center, Wuhan 430071, PR China.
Gene. 2018 Nov 15;676:329-335. doi: 10.1016/j.gene.2018.08.064. Epub 2018 Aug 23.
Recently, microRNAs (miRNAs) have been emerged as critical regulators for human diseases and as prognostic markers in several tumors, including colorectal carcinoma (CRC). Herein, we identified a tumor-suppressive miRNA, miR-202-5p, which may suppress CRC tumorigenesis. SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 1 (SMARCC1) is a susceptibility gene in CRC. However, the role of SMARCC1 in CRC tumorigenesis has not been elucidated. In our present study, we demonstrated that miR-202-5p was a tumor-suppressive miRNA in CRC progression. We found that expression of miR-202-5p was obviously decreased in CRC tissues. Down-regulation of miR-202-5p was associated with postoperative survival. Overexpression of miR-202-5p inhibited the growth and metastasis of CRC cells. The SMARCC1 was a direct target of miR-202-5p and promoted the growth and metastasis of CRC cells. Further study showed that SMARCC1 could reverse the inhibitory effect of miR-202-5p on growth and metastasis of CRC cells. In conclusion, our data highlight the key role of miR-202-5p in the progression of CRC. Thus, miR-202-5p may be a potential prognostic marker and of treatment relevance for CRC progression intervention.
最近,microRNAs(miRNAs)已成为人类疾病的关键调控因子,也是包括结直肠癌(CRC)在内的几种肿瘤的预后标志物。在此,我们鉴定出一种肿瘤抑制 miRNA,miR-202-5p,它可能抑制 CRC 的肿瘤发生。SWI/SNF 相关、基质相关、肌动蛋白依赖染色质调节剂亚家族 c 成员 1(SMARCC1)是 CRC 的易感基因。然而,SMARCC1 在 CRC 肿瘤发生中的作用尚未阐明。在本研究中,我们证明了 miR-202-5p 是 CRC 进展中的肿瘤抑制 miRNA。我们发现 miR-202-5p 的表达在 CRC 组织中明显降低。miR-202-5p 的下调与术后生存有关。miR-202-5p 的过表达抑制 CRC 细胞的生长和转移。SMARCC1 是 miR-202-5p 的直接靶标,并促进 CRC 细胞的生长和转移。进一步的研究表明,SMARCC1 可以逆转 miR-202-5p 对 CRC 细胞生长和转移的抑制作用。总之,我们的数据强调了 miR-202-5p 在 CRC 进展中的关键作用。因此,miR-202-5p 可能是 CRC 进展干预的潜在预后标志物和治疗相关性。